PL2675453T3 - Sposoby zwalczania bólu u psów z zastosowaniem przezskórnego roztworu fenantylu - Google Patents

Sposoby zwalczania bólu u psów z zastosowaniem przezskórnego roztworu fenantylu

Info

Publication number
PL2675453T3
PL2675453T3 PL12704486T PL12704486T PL2675453T3 PL 2675453 T3 PL2675453 T3 PL 2675453T3 PL 12704486 T PL12704486 T PL 12704486T PL 12704486 T PL12704486 T PL 12704486T PL 2675453 T3 PL2675453 T3 PL 2675453T3
Authority
PL
Poland
Prior art keywords
canines
fentanyl
methods
controlling pain
transdermal solution
Prior art date
Application number
PL12704486T
Other languages
English (en)
Inventor
Garret Conrad Newbound
Terrence Patrick Clark
Original Assignee
Elanco Us Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Us Inc. filed Critical Elanco Us Inc.
Publication of PL2675453T3 publication Critical patent/PL2675453T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12704486T 2011-02-15 2012-02-08 Sposoby zwalczania bólu u psów z zastosowaniem przezskórnego roztworu fenantylu PL2675453T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161442884P 2011-02-15 2011-02-15
PCT/US2012/024218 WO2012112348A1 (en) 2011-02-15 2012-02-08 Methods for controlling pain in canines using a transdermal solution of fentanyl
EP12704486.5A EP2675453B1 (en) 2011-02-15 2012-02-08 Methods for controlling pain in canines using a transdermal solution of fentanyl

Publications (1)

Publication Number Publication Date
PL2675453T3 true PL2675453T3 (pl) 2018-12-31

Family

ID=45615076

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12704486T PL2675453T3 (pl) 2011-02-15 2012-02-08 Sposoby zwalczania bólu u psów z zastosowaniem przezskórnego roztworu fenantylu

Country Status (22)

Country Link
US (1) US8603984B2 (pl)
EP (1) EP2675453B1 (pl)
JP (1) JP2014505726A (pl)
KR (1) KR101526781B1 (pl)
CN (1) CN103384524A (pl)
AU (1) AU2012218007B2 (pl)
BR (1) BR112013020775A2 (pl)
CA (1) CA2827435C (pl)
CL (1) CL2013002322A1 (pl)
CO (1) CO6751269A2 (pl)
DK (1) DK2675453T3 (pl)
EA (1) EA201391023A1 (pl)
ES (1) ES2688288T3 (pl)
HU (1) HUE041353T2 (pl)
IL (1) IL227292A0 (pl)
MX (1) MX2013009468A (pl)
PH (1) PH12013501685A1 (pl)
PL (1) PL2675453T3 (pl)
PT (1) PT2675453T (pl)
SG (1) SG192782A1 (pl)
WO (1) WO2012112348A1 (pl)
ZA (1) ZA201305341B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110092922A1 (en) * 2009-10-19 2011-04-21 Trompen Mick A Transdermal dispensing apparatus and methods
US9375417B2 (en) * 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
US10028904B2 (en) 2014-12-04 2018-07-24 Wisconsin Alumni Research Foundation Transdermal cannabinoid formulations
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0629191B2 (ja) * 1984-09-04 1994-04-20 株式会社ポリトロニクス 抗腫瘍剤、抗ウィルス剤
BR9105371A (pt) * 1990-12-20 1992-08-25 Lilly Co Eli Formulacao apropriada para a administracao transdermica de dobutamina e processo para aumentar a contratilidade cardiaca
US6916486B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6660768B2 (en) * 2001-02-08 2003-12-09 Schering-Plough Animal Health Corporation Parasiticidal compositions and methods of use
JP5160018B2 (ja) * 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
AUPS317102A0 (en) * 2002-06-25 2002-07-18 Drug Delivery Solutions Pty Ltd Transdermal aerosol compositions
JP2004123545A (ja) * 2002-09-30 2004-04-22 Sumitomo Chem Co Ltd 動物外部寄生虫防除用経皮投与剤
US7309593B2 (en) 2003-10-01 2007-12-18 Surmodics, Inc. Attachment of molecules to surfaces
EP1694400A1 (en) * 2003-11-28 2006-08-30 Acrux DDS Pty Ltd Method and system for rapid transdermal administration
WO2009047779A2 (en) * 2007-06-20 2009-04-16 Nikki Nikhilesh Singh Composition containing fentanyl base aromatic oils and alkyl salicylate for the delivery of fentanyl base in vapour form
ES2654641T3 (es) 2009-07-01 2018-02-14 Locata Corporation Pty Ltd Método y aparato para formar un haz
US20110092922A1 (en) * 2009-10-19 2011-04-21 Trompen Mick A Transdermal dispensing apparatus and methods

Also Published As

Publication number Publication date
EP2675453A1 (en) 2013-12-25
KR101526781B1 (ko) 2015-06-05
HUE041353T2 (hu) 2019-05-28
EP2675453B1 (en) 2018-08-08
US20120208849A1 (en) 2012-08-16
PH12013501685A1 (en) 2018-03-21
PT2675453T (pt) 2018-11-07
CN103384524A (zh) 2013-11-06
SG192782A1 (en) 2013-09-30
WO2012112348A1 (en) 2012-08-23
KR20130116331A (ko) 2013-10-23
MX2013009468A (es) 2013-09-06
ES2688288T3 (es) 2018-10-31
CO6751269A2 (es) 2013-09-16
CL2013002322A1 (es) 2013-12-27
IL227292A0 (en) 2013-09-30
EA201391023A1 (ru) 2014-01-30
JP2014505726A (ja) 2014-03-06
ZA201305341B (en) 2015-01-28
DK2675453T3 (en) 2018-10-29
NZ613021A (en) 2015-02-27
CA2827435A1 (en) 2012-08-23
CA2827435C (en) 2018-11-27
US8603984B2 (en) 2013-12-10
AU2012218007B2 (en) 2015-08-06
BR112013020775A2 (pt) 2016-10-11

Similar Documents

Publication Publication Date Title
EP2717958A4 (en) TRANSDERMALE DEVICE WITH MICRONED PINS
EP2680918A4 (en) TRANSDERMAL STAMP CONTAINING MICROARRAYS
EP2720719A4 (en) METHOD FOR SELECTION OF THERAPEUTIC INDICATIONS
ZA201400066B (en) Driving and controlling method for biomimetic fish and biomimetic fish
DK2687205T3 (da) Fentanyl transdermal plaster
SMT201600038B (it) Composizione per una stimolazione ovarica controllata
SG11201504372UA (en) A method of purifying therapeutic proteins
IL230433A0 (en) Pain management methods
IL232292A0 (en) Preparations containing a substance with anti-conoxin activity and their use for increasing anti-conoxin activity and their use for increasing the activity of acetylcholinesterase inhibitors
ZA201403497B (en) Transdermal therapeutic system for administering fentanyl or analogue thereof
PT2750673T (pt) Sistema terapêutico transdérmico para cloridrato do ácido 5-aminolevulínico
ZA201403739B (en) Methods of treatment with deferiprone
ZA201502595B (en) Therapeutic methods
EP2753395A4 (en) METHOD AND DEVICE FOR TRANSDERMAL DELIVERY OF SUBSTANCES
ZA201305341B (en) Methods for controlling pain in canines using a transdermal solution of fentanyl
EP2662092A4 (en) METHOD FOR SELECTING PATIENTS FOR THE ADMINISTRATION OF MEDICAMENTS FOR THE TREATMENT OF SEPSIS
SG10201603199VA (en) A method and a system for controlling discomfort level
ZA201308176B (en) Therapeutic treatment
PL2675454T3 (pl) Sposoby kontrolowania bólu u koniowatych przy zastosowaniu przezskórnego roztworu fentanylu
HK1188932A (en) Methods for controlling pain in canines using a transdermal solution of fentanyl
ZA201107270B (en) A skin treatment composition
GB201116826D0 (en) Transdermal hair growth optimiser
GB201117347D0 (en) Transdermal male-specific hair growth optimiser
SG10201911709RA (en) A method of purifying therapeutic proteins
GB201100455D0 (en) Methods relating to treatment